Assessment of the Efficacy of FOSFOMYCIN in Patients With Bacterial Infection
Assessment of the Efficacy of FOSFOMYCIN in Patients With Bacterial Infection
This project aims to assess the clinical and microbiological efficacy of fosfomycin(FOM) in
 patients with bacterial infection.

 Primary objective:

 • To assess clinical and microbiological efficacy of FOM in patients with bacterial
 infection.

 Secondary objectives:

 -  To determine the rate and severity of unexpected adverse events.

 -  To determine the mean duration of therapy with FOM in patients with bacterial infection.

 Study design:

 Multi-center, non-interventional study
Please note that InfectoPharm Arzneimittel und Consilium GmbH has taken over sponsor
 responsibilities for all German sites of this clinical trial with Jannuary 2016 from J&P
 MEDICAL RESEARCH LTD.
Inclusion Criteria:

 -  Patients with bacterial infection receiving FOM for clinical purposes will be included
 into the analysis.

 Exclusion Criteria:

 -